Unresectable cutaneous melanoma
Clinical trials for Unresectable cutaneous melanoma explained in plain language.
Never miss a new study
Get alerted when new Unresectable cutaneous melanoma trials appear
Sign up with your email to follow new studies for Unresectable cutaneous melanoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive drug targets Hard-to-Treat melanoma in early trial
Disease control Stopped earlyThis early-stage trial tests a radioactive drug called [225Ac]Ac-A9-3408 in 50 adults with melanoma that has spread or can't be removed by surgery. The main goals are to find a safe dose and check for side effects. Participants receive the drug every 6 weeks for up to 6 doses, an…
Matched conditions: UNRESECTABLE CUTANEOUS MELANOMA
Phase 1 • Sponsor: Alpha-9 Oncology USA Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Early trial of PF-08046031 for advanced cancers ends early
Disease control Stopped earlyThis early-stage study tested a new drug called PF-08046031 in 11 adults with advanced melanoma or other solid tumors that had spread or had no standard treatment options. The main goal was to check the drug's safety and side effects. The trial was terminated early, so its findin…
Matched conditions: UNRESECTABLE CUTANEOUS MELANOMA
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC